Kymera Therapeutics, Inc.
KYMR
Kedudukan dalam Saham
#2152
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to... Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
Harga Saham
$113.68
Disegerakkan terakhir: 2026-10-21
Modal Pasaran
$9.35B
Perubahan (1 hari)
0.19%
Perubahan (1 tahun)
103.73%
Negara
US
Perdagangan Kymera Therapeutics, Inc. (KYMR)
Kategori
Healthcare
Sejarah harga saham bagi Kymera Therapeutics, Inc. (KYMR)
Harga penutupan tertinggi: $109.14 pada 2026-10-01
Harga penutupan terendah: $31.67 pada 2020-08-01
Harga penutupan terendah: $31.67 pada 2020-08-01
Sejarah harga saham Kymera Therapeutics, Inc. dari 2020 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2026 (TTM) | 12.05% |
| 2025 | 87.59% |
| 2024 | 77.01% |
| 2023 | -11.39% |
| 2022 | -52.05% |
| 2021 | -12.80% |
| 2020 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $756.75 | 7.56% |
CH
|
